Legend Biotech Sustainability Profile
Legend Biotech Corporation, a prominent player in the biotechnology industry, is headquartered in the United States. Founded in 2014, the company has rapidly established itself as a leader in cell therapy, particularly in the development of innovative treatments for cancer. With a focus on CAR-T cell therapies, Legend Biotech's flagship product, cilta-cel, has garnered significant attention for its unique approach to targeting multiple myeloma. Operating primarily in the US and expanding its reach globally, Legend Biotech has achieved notable milestones, including strategic partnerships and advancements in clinical trials. The company is recognised for its commitment to advancing personalised medicine, positioning itself at the forefront of the biopharmaceutical landscape. With a robust pipeline and a dedication to transformative therapies, Legend Biotech continues to make significant strides in improving patient outcomes.
DitchCarbon Score
How does Legend Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Legend Biotech's score of 59 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Legend Biotech's reported carbon emissions
In 2024, Legend Biotech reported total emissions of approximately 12,715,000 kg CO2e, comprising 769,000 kg CO2e from Scope 1 and about 11,945,000 kg CO2e from Scope 2 (market-based). In 2023, the company recorded total emissions of around 12,973,530 kg CO2e, with Scope 1 emissions at 770,000 kg CO2e and Scope 2 emissions at approximately 12,204,000 kg CO2e (market-based). Despite these figures, Legend Biotech has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The emissions data is cascaded from their parent company, Genscript Biotech Corporation, indicating a corporate family relationship that influences their sustainability reporting. Legend Biotech's headquarters is located in the US, and while they have not set formal reduction targets, their emissions data reflects a commitment to transparency in their environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 770,000 | 000,000 |
| Scope 2 | 12,204,000 | 00,000,000 |
| Scope 3 | - | - |
How Carbon Intensive is Legend Biotech's Industry?
How Carbon Intensive is Legend Biotech's Location?
Legend Biotech's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Legend Biotech has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
